Abdullahi v. Pfizer, Inc. (original) (raw)
The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the pharmaceutical company Pfizer in 1996 in Kano, Nigeria, during an epidemic of meningococcal meningitis. To test its new antibiotic, trovafloxacin (Trovan), Pfizer gave 100 children trovafloxacin, while another 100 received the gold-standard anti-meningitis treatment, ceftriaxone, a cephalosporin antibiotic. Pfizer gave the children a substantially reduced dose of the ceftriaxone (specifically, 33 mg/kg) relative to that described on the US FDA-approved prescribing information. The allegation is that this was done to skew the test in favor of its own drug. Pfizer claimed that the dose used was sufficient even though a clinical trial performed by Médecins Sans Frontières recommends a dose of 50–100 mg/kg.
| Property | Value |
|---|---|
| dbo:abstract | The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the pharmaceutical company Pfizer in 1996 in Kano, Nigeria, during an epidemic of meningococcal meningitis. To test its new antibiotic, trovafloxacin (Trovan), Pfizer gave 100 children trovafloxacin, while another 100 received the gold-standard anti-meningitis treatment, ceftriaxone, a cephalosporin antibiotic. Pfizer gave the children a substantially reduced dose of the ceftriaxone (specifically, 33 mg/kg) relative to that described on the US FDA-approved prescribing information. The allegation is that this was done to skew the test in favor of its own drug. Pfizer claimed that the dose used was sufficient even though a clinical trial performed by Médecins Sans Frontières recommends a dose of 50–100 mg/kg. Five children given trovafloxacin died, as did six of those given ceftriaxone. The lead investigator, Abdulhamid Isa Dutse, later provided a letter of approval for human trials that was found to be falsified. The Nigerian government called the trial "an illegal trial of an unregistered drug". It has been alleged that participants and their families were not told that they were part of a trial, and that Médecins Sans Frontières was offering the standard treatment in another part of the same building. Pfizer acknowledged reducing the dose of the standard treatment, but said this was done to minimize injection-site pain and that the mortality rates in both the trovafloxin and ceftriaxone arms of its trial were lower than among those treated with chloramphenicol by Médecins Sans Frontières. The survivors of the trial tried to bring a number of legal actions against Pfizer in the United States. These resulted in four judicial opinions, the first three dismissing the claims on procedural grounds. According to Ben Goldacre, Pfizer argued that it was not required to obtain informed consent for experimental drug trials in Africa, and that any case should be heard in Nigeria. In May 2006, Representative Tom Lantos of California, the senior Democrat on the House International Relations Committee, described the findings of a report compiled about the case by the Nigerian government as "absolutely appalling" and called for Pfizer to open its records. In January 2009, the United States Court of Appeals for the Second Circuit ruled that the Nigerian victims and their families were entitled to bring suit against Pfizer in the United States under the Alien Tort Statute. Pfizer subsequently settled the case out of court with a $75 million settlement that was subject to a confidentiality clause. Overall, the 1996 meningitis epidemic in northern Nigeria killed about 12,000 people, during the worst known meningitis outbreak in Sub-Saharan Africa. (en) Con l'espressione contenzioso di Kano si fa riferimento ad un insieme di casi giudiziari che vedono coinvolta la multinazionale farmaceutica Pfizer in seguito ad alcuni eventi accaduti nel 1996, quando – nel corso di una grave epidemia nella città di Kano, in Nigeria – diversi bambini furono oggetto di una sperimentazione umana non autorizzata. Tale sperimentazione non era stata preventivamente concordata né con le competenti autorità nigeriane, né con i genitori. Gli interventi riguardarono bambini malati di meningite da meningococco, cui fu somministrata trovafloxacina – un antibiotico sperimentale – invece della ben più documentata terapia a base di ceftriaxone. Secondo le accuse mosse alla Pfizer, i decessi e le lesioni gravi registratisi in seguito alla sperimentazione sarebbero imputabili al protocollo usato; a sua difesa, la multinazionale sostiene che il proprio farmaco è risultato efficace almeno quanto la migliore terapia disponibile all'epoca dei fatti. L'intera vicenda venne alla ribalta dell'opinione pubblica dopo un'inchiesta del Washington Post del dicembre 2000, suscitando un notevole clamore a livello internazionale. Ad oggi il caso è oggetto di due controversie legali, una negli Stati Uniti ed una in Nigeria. Agli episodi di Kano è ispirata la trama del romanzo Il giardiniere tenace di John le Carré, dal quale è stato tratto anche un adattamento cinematografico. (it) |
| dbo:thumbnail | wiki-commons:Special:FilePath/LocationNigeria.svg?width=300 |
| dbo:wikiPageExternalLink | http://media.pfizer.com/files/news/trovan_statement_defense_summary.pdf https://web.archive.org/web/20101121135119/http:/media.pfizer.com/files/news/trovan_statement_defense_summary.pdf |
| dbo:wikiPageID | 10883987 (xsd:integer) |
| dbo:wikiPageLength | 27947 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1119041682 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Bacterial_meningitis dbr:President_of_the_United_States dbr:Rome dbr:Epidemic dbr:Motion_(legal) dbr:Meningism dbr:Ben_Goldacre dbr:Blindness dbr:Democratic_Party_(United_States) dbr:Animal_testing dbr:Pfizer dbr:Pharmaceutical_company dbr:Customary_international_law dbr:United_Nations dbr:United_States dbr:United_States_Court_of_Appeals_for_the_Second_Circuit dbr:United_States_District_Court_for_the_Southern_District_of_New_York dbr:Universal_Declaration_of_Human_Rights dbr:Deafness dbr:Declaration_of_Helsinki dbr:Informed_consent dbr:International_law dbr:Alien_Tort_Claims_Act dbr:State_actor dbr:U.S._State_Department dbr:Connecticut dbr:Measles dbr:English_language dbr:Médecins_Sans_Frontières dbr:Osteochondrosis dbr:Appeal dbr:Choice_of_law dbr:Sub-Saharan_Africa dbr:Demurrer dbr:Paralysis dbr:Medical_experimentation_in_Africa dbr:Ceftriaxone dbr:Cephalosporin dbr:Tom_Lantos dbr:Trovafloxacin dbr:Nuremberg_Code dbr:Abdulhamid_Isa_Dutse dbr:Alien_Tort_Statute dbc:1996_in_United_States_case_law dbr:European_Union dbr:Food_and_Drug_Administration dbr:Nigeria dbr:Forum_non_conveniens dbr:Judicial_notice dbr:Judicial_opinion dbr:Procedural_law dbr:International_Covenant_on_Civil_and_Political_Rights dbr:Italy dbr:The_Constant_Gardener_(film) dbc:Clinical_trials dbc:1996_in_Nigeria dbc:Alien_Tort_Statute_case_law dbc:Fluoroquinolone_antibiotics dbc:Medical_controversies_in_Nigeria dbc:Nigeria–United_States_relations dbc:Pfizer_litigation dbr:Affidavit dbr:African_meningitis_belt dbr:Chloramphenicol dbr:Cholera dbr:Jimmy_Carter dbr:Kano_(city) dbr:Kano_State dbr:Supreme_Court_of_the_United_States dbr:Hepatotoxicity dbr:Doctors_Without_Borders dbr:Meningococcal_meningitis dbr:ICCPR dbr:World_Health_Organization dbr:Yakubu_Gowon dbr:Implied_cause_of_action dbr:Liver_failure dbr:Substantive_law dbr:Teva_Canada_Ltd._v._Pfizer_Canada_Inc. dbr:The_Constant_Gardener dbr:Northern_Nigeria dbr:House_International_Relations_Committee dbr:Settlement_(law) dbr:CIOMS dbr:Human_experimentation dbr:Subject_matter_jurisdiction dbr:Connecticut_Products_Liability_Statute dbr:Connecticut_Unfair_Trade_Practices_Act dbr:File:LocationNigeria.svg dbr:File:Trovafloxacin.svg dbr:File:USSupremeCourtWestFacade.JPG dbr:File:US_Court_of_Appeals_and_District_Court_map.svg |
| dbp:date | 2010-11-21 (xsd:date) |
| dbp:url | https://web.archive.org/web/20101121135119/http:/media.pfizer.com/files/news/trovan_statement_defense_summary.pdf |
| dbp:wikiPageUsesTemplate | dbt:Citation_needed dbt:Italic_title dbt:Reflist dbt:Short_description dbt:Webarchive dbt:Medical_ethics dbt:Medical_ethics_cases dbt:Research_participant_rights |
| dct:subject | dbc:1996_in_United_States_case_law dbc:Clinical_trials dbc:1996_in_Nigeria dbc:Alien_Tort_Statute_case_law dbc:Fluoroquinolone_antibiotics dbc:Medical_controversies_in_Nigeria dbc:Nigeria–United_States_relations dbc:Pfizer_litigation |
| rdf:type | yago:WikicatClinicalTrials yago:WikicatMedicalControversies yago:WikicatTrials yago:Abstraction100002137 yago:Act100030358 yago:Activity100407535 yago:Attempt100786195 yago:ClinicalTrial100792356 yago:Controversy107183151 yago:Disagreement107180787 yago:Dispute107181935 yago:Event100029378 yago:PsychologicalFeature100023100 yago:YagoPermanentlyLocatedEntity yago:SpeechAct107160883 yago:Test100791078 |
| rdfs:comment | The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the pharmaceutical company Pfizer in 1996 in Kano, Nigeria, during an epidemic of meningococcal meningitis. To test its new antibiotic, trovafloxacin (Trovan), Pfizer gave 100 children trovafloxacin, while another 100 received the gold-standard anti-meningitis treatment, ceftriaxone, a cephalosporin antibiotic. Pfizer gave the children a substantially reduced dose of the ceftriaxone (specifically, 33 mg/kg) relative to that described on the US FDA-approved prescribing information. The allegation is that this was done to skew the test in favor of its own drug. Pfizer claimed that the dose used was sufficient even though a clinical trial performed by Médecins Sans Frontières recommends a dose of 50–100 mg/kg. (en) Con l'espressione contenzioso di Kano si fa riferimento ad un insieme di casi giudiziari che vedono coinvolta la multinazionale farmaceutica Pfizer in seguito ad alcuni eventi accaduti nel 1996, quando – nel corso di una grave epidemia nella città di Kano, in Nigeria – diversi bambini furono oggetto di una sperimentazione umana non autorizzata. (it) |
| rdfs:label | Abdullahi v. Pfizer, Inc. (en) Contenzioso di Kano (it) |
| owl:sameAs | freebase:Abdullahi v. Pfizer, Inc. yago-res:Abdullahi v. Pfizer, Inc. wikidata:Abdullahi v. Pfizer, Inc. dbpedia-it:Abdullahi v. Pfizer, Inc. https://global.dbpedia.org/id/3QAS7 |
| prov:wasDerivedFrom | wikipedia-en:Abdullahi_v._Pfizer,_Inc.?oldid=1119041682&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/Trovafloxacin.svg wiki-commons:Special:FilePath/US_Court_of_Appeals_and_District_Court_map.svg wiki-commons:Special:FilePath/LocationNigeria.svg wiki-commons:Special:FilePath/USSupremeCourtWestFacade.jpg |
| foaf:isPrimaryTopicOf | wikipedia-en:Abdullahi_v._Pfizer,_Inc. |
| is dbo:wikiPageRedirects of | dbr:Kano_Trovafloxacin_trial_litigation dbr:Pfizer_in_Nigeria_Litigation. dbr:Abdullahi_v._Pfizer,_Inc dbr:Kano_trovafloxacin_trial_litigation |
| is dbo:wikiPageWikiLink of | dbr:Blood_and_Henna dbr:Kano_Trovafloxacin_trial_litigation dbr:Bad_Pharma dbr:Abdulhamid_Isa_Dutse dbr:Teva_Canada_Ltd_v_Pfizer_Canada_Inc dbr:The_Constant_Gardener_(film) dbr:The_Constant_Gardener dbr:Unethical_human_experimentation dbr:Pfizer_in_Nigeria_Litigation. dbr:Abdullahi_v._Pfizer,_Inc dbr:Kano_trovafloxacin_trial_litigation |
| is foaf:primaryTopic of | wikipedia-en:Abdullahi_v._Pfizer,_Inc. |
